Medical Devices; Anesthesiology Devices; Classification of the Adjunctive Pain Measurement Device for Anesthesiology
Key claim: The FDA is classifying the adjunctive pain measurement device for anesthesiology as Class II (special controls) to provide reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patient access.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the adjunctive pain measurement device for anesthesiology into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the adjunctive pain measurement device for anesthesiology. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Class II classification with special controls establishes a defined regulatory pathway (typically via 510(k) clearance) for adjunctive pain measurement devices, which can shorten time-to-market for manufacturers and expand clinician access to objective pain-monitoring tools during anesthesia. For patients, it signals FDA acceptance of a device category intended to supplement — not replace — clinical pain assessment, with safety and performance requirements standardized across future entrants.